CLINICAL ROLE -
Multiple Myeloma Pipeline Offers Promising New Options for Treatment
Novel therapeutics under investigation include CAR T-cell therapies, antibody-drug conjugates, and bispecific antibodies, as well as other unique drugs.
Read More